Comment on: Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia
- PMID: 39559845
- DOI: 10.1093/jac/dkae417
Comment on: Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia
Comment in
-
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia-authors' response.J Antimicrob Chemother. 2025 Apr 2;80(4):1162-1164. doi: 10.1093/jac/dkaf059. J Antimicrob Chemother. 2025. PMID: 40036560 No abstract available.
Comment on
-
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia.J Antimicrob Chemother. 2024 Jul 1;79(7):1547-1554. doi: 10.1093/jac/dkae129. J Antimicrob Chemother. 2024. PMID: 38727613 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
